| Description | Dosimertinib-d3 is a potent, orally active inhibitor of EGFR, known to reduce the expression of p-EGFR and p-ERK proteins, thereby exhibiting antiproliferative and anti-tumor effects. It holds promise for research into non-small-cell lung cancer (NSCLC). |
| molecular weight | 504.64 |
| Molecular formula | C28H28D5N7O2 |
| CAS | 2403760-70-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |